small molecule

HEMADY

DEXAMETHASONE

Loss of exclusivityDecember 2037latest FDA-listed patent expiry

CompanyDEXCEL PHARMA TECHNOLOGIES LTD

Drug detail

Brand name	HEMADY
Active ingredient	DEXAMETHASONE
Strength	20MG
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	October 2019
Marketing status	RX

Listed patents

Patent	Expires	Type
11304961	December 2037	product
10537585	December 2037	product

Regulatory exclusivity

Code	Expires
ODE-271	October 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from DEXCEL PHARMA TECHNOLOGIES LTD